How Transcatheter Mitral Clip Repair Reduces Regurgitation by Joining the Valve Leaflets

The echocardiogram report is two pages long, but one word keeps pulling the eye: severe. A woman in her late seventies reads it at her kitchen table with a grandson translating the abbreviations. Mitral regurgitation. Not a candidate for open surgery. Then a phrase she has never heard: edge-to-edge repair, done through a vein in the groin, with a clip smaller than a fingernail.

Her first question is the one nearly everyone asks: how can a clip fix a leak? Understanding how mitral valve clip repair works turns out to be surprisingly intuitive once you picture the valve as a pair of swinging doors that no longer shut. The clip does not replace the doors. It pinches them together in the middle, so each half closes on a smaller frame.

This explainer walks through that mechanism, the evidence behind it, who tends to be offered the procedure, what recovery usually looks like, and the honest limits of what a clip can and cannot do.

What mitral regurgitation is, and why a backward leak wears the heart down

The mitral valve sits between the two left chambers of the heart, the atrium above and the ventricle below. It has two leaflets, thin flaps of tissue tethered by cord-like strings called chordae to small muscles in the ventricle wall. When the ventricle squeezes, the leaflets should swing shut and meet edge to edge, sealing the chamber so blood is pushed forward into the aorta and out to the body.

Mitral regurgitation means the seal fails. With every beat, a portion of blood squirts backward into the left atrium instead of forward. The heart compensates by pumping harder and by stretching to hold the extra volume returning to it. Over months and years, that stretching enlarges the atrium, raises pressure in the lung circulation, and can tip the ventricle into a weakened state. MedlinePlus describes the typical result: breathlessness with exertion and then at rest, fatigue, swollen ankles, and sometimes palpitations from atrial fibrillation, a chaotic rhythm that an enlarged atrium is prone to develop.

Severity is graded by echocardiography, an ultrasound of the heart. Cardiologists measure how wide the leaking jet is, how much blood goes backward per beat, and how the chambers have changed in size. Mild leaks are common and often need nothing more than periodic checks; the NHS notes that many people with mild mitral valve problems have no symptoms at all. Severe leaks with symptoms, or with signs that the ventricle is beginning to fail, are the ones that prompt a conversation about repair.

Two details from this anatomy matter for everything that follows. First, the leaflets normally overlap by several millimeters when closed, so there is spare tissue to work with. Second, the leak usually comes from a specific spot along the line where the leaflets meet, not from the whole valve. A clip exploits both facts.

How mitral valve clip repair works: joining two leaflets into one seam

Picture a pair of saloon doors that have sagged so they no longer meet in the middle. One repair is to rehang the doors. Another is simpler: fasten the two doors together at their free edges with a single hinge in the center. Each door now closes against the hinge rather than against the other door, and the gap disappears. The doorway becomes two smaller doorways. That is how mitral valve clip repair works.

The clip is a small device with two arms, roughly the width of a fingertip, made of a cobalt-chromium alloy and covered in polyester fabric that encourages the body’s own tissue to grow over it. During the procedure it is delivered closed, opened beneath the valve, and then positioned so that the free edge of each leaflet rests on one arm. Small grippers fold down to hold the tissue, the arms are closed, and the two leaflets are held together at that point. The cardiology team checks on live ultrasound how much leak remains. If the result is not good enough, the clip can be reopened, repositioned, or removed entirely before it is released. Once released, it stays in place permanently.

The principle borrows directly from an open-surgery technique in which a surgeon places a stitch through both leaflet edges to create a double-orifice valve. The transcatheter version reaches the same anatomy from inside a beating heart, through a vein, without stopping the heart or opening the chest.

One clip is often enough. When the leak spans a longer stretch of the leaflet edge, a second clip beside the first is common, and occasionally a third. Each additional clip narrows the opening a little more, so the team balances leak reduction against the risk of making the valve too tight, a trade-off explored later in this article.

What actually happens in the catheter lab, step by step

The procedure takes place in a cardiac catheterization laboratory or a hybrid operating room, under general anesthesia. Anesthesia is used less for pain than for stillness: the team relies on transesophageal echocardiography, an ultrasound probe passed down the throat that gives a close, continuous view of the mitral valve, and the probe is uncomfortable in an awake patient.

Access is through the femoral vein at the top of the thigh, the same route used for many pacemaker and rhythm procedures. A catheter travels up into the right atrium. The valve, however, is on the left side, so the operator crosses the thin wall between the two atria with a needle puncture called a transseptal puncture. The location of that puncture is chosen deliberately, because the height above the valve determines whether the clip can be angled correctly onto the leaflets.

A steerable guide sheath, about as thick as a drinking straw, is then advanced into the left atrium. The clip delivery system passes through it. Using both X-ray and echocardiography, the operator steers the closed clip above the leaking segment, opens the arms, and lowers it through the valve into the ventricle. The clip is drawn back up so that each leaflet edge catches on an arm, the grippers close, and the arms clamp.

Then comes the assessment. The echocardiographer measures the remaining leak, checks the pressure gradient across the now-smaller opening, and confirms that both leaflets are securely held. Only when the team is satisfied is the clip released. The catheters are withdrawn, the vein is closed with a stitch or a closure device, and pressure is applied.

Mayo Clinic describes the whole process as typically taking a few hours, though complex anatomy or a second clip can extend it. The small hole left in the atrial wall usually closes on its own over the following months; when it does not, it is often small enough to leave alone.

Why a double orifice leaks less: the mechanics behind the clip

Several things change when the leaflets are pinned together, and each contributes to a smaller leak.

The most obvious is geometry. In a healthy valve the leaflet edges meet along a curved line nearly four centimeters long. In a leaking valve, part of that line has a gap: either one leaflet flops back into the atrium because a chord has snapped, or the ventricle has stretched so far that the leaflets are pulled apart and cannot reach one another. The clip removes the gap at its widest point and anchors the surrounding tissue. Leaflet segments on either side of the clip now have less distance to travel before they meet, so the seam closes more completely.

The second effect is on the annulus, the ring of tissue the leaflets hang from. Joining the leaflets pulls the front and back of the ring toward each other, shortening the front-to-back diameter. A smaller ring is easier for the leaflets to cover. Echocardiographic studies from the early trials, including the EVEREST II series published in the New England Journal of Medicine, recorded this reduction in annular dimension after clip placement.

The third effect unfolds over months. With less blood sloshing backward, the left atrium and ventricle handle a smaller volume load. The chambers can shrink toward a more normal size, which in turn tightens the ring and improves how the leaflets meet. This is why some people see their residual leak grade drift downward on follow-up echocardiograms rather than upward.

None of this restores the valve to new. A repaired valve typically retains a mild or mild-to-moderate leak, and it has a smaller total opening than before. Cardiologists accept that trade because the mechanical goal is not perfection; it is to reduce the backward volume enough to unload the heart and relieve symptoms.

Primary versus secondary mitral regurgitation: why the cause changes the answer

Two very different problems produce the same word on an echo report. Telling them apart is the single most important step in deciding whether a clip is the right tool.

Primary, or degenerative, regurgitation is a disease of the valve itself. The leaflets may be floppy and enlarged, a chord may have ruptured so that a segment flails backward, or old rheumatic scarring may have distorted the tissue. The heart muscle is often normal at first. Here the leaflets are the problem, and a repair that fixes the leaflets addresses the root cause. Surgery has long been the reference treatment for people fit enough to undergo it, and the clip is generally reserved for those judged too frail or too high-risk for an operation.

Secondary, or functional, regurgitation is different. The leaflets are structurally normal. The trouble is that the left ventricle has enlarged and weakened, usually after a heart attack or from a cardiomyopathy, and the stretched chamber pulls the leaflets apart. The valve leaks because the room around it has changed shape. Treating the leak does not treat the underlying muscle disease, which is why guideline committees insist that people with secondary regurgitation receive optimized heart-failure medicines first, and a clip only if a meaningful leak persists despite them.

This distinction explains an apparent contradiction in the research. Two randomized trials of clip repair for secondary regurgitation, published within weeks of each other, reached opposite conclusions. The likely reason, discussed in the evidence section below, is that they enrolled patients whose leaks and ventricles were proportioned differently. When the leak is large relative to the size of the ventricle, fixing it seems to help; when the ventricle is enormous and the leak modest by comparison, the muscle disease dominates and the clip changes little.

Who is usually offered a mitral valve TEER procedure, and who is asked to wait

The mitral valve TEER procedure is not a first-line option for most people with a leaking valve, and understanding why helps set expectations.

Candidates commonly fall into two groups. The first is people with severe primary regurgitation and symptoms who have been assessed by a heart team, a group that includes a cardiac surgeon, an interventional cardiologist, and an imaging specialist, and judged to be at high or prohibitive risk for open surgery. Age alone does not define that risk; frailty, lung disease, prior chest surgery, kidney function, and a weak ventricle all count. The second group is people with severe secondary regurgitation and heart-failure symptoms that persist despite guideline-directed medicines, whose ventricle is enlarged but not so severely damaged that the valve is no longer the dominant problem. The COAPT trial, cited in the references, defined this second group with specific echocardiographic limits on ventricle size and pumping strength.

Anatomy matters as much as the clinical picture. The leaflets must be long enough and mobile enough to be grasped, the valve opening must be wide enough that a clip will not leave it too narrow, and the leak must come from a segment the clip can reach. Heavy calcium in the leaflet edges, a very short posterior leaflet, or a hole in the leaflet body can rule the procedure out.

People who are usually asked to wait, or steered elsewhere, include those with mild or moderate regurgitation, those whose symptoms have another explanation, those with secondary regurgitation who have not yet had a proper trial of heart-failure medicines, and those who are good surgical candidates with primary disease, for whom surgical repair remains the standard of care. Someone with an active infection of the valve, or a blood clot in the left atrium, is deferred until that is resolved. The decision in every case rests with the treating heart team, informed by imaging and by the person’s own priorities.

Mitral regurgitation treatment options compared

Clip repair is one of several ways to manage a leaking mitral valve. The right choice depends on the cause, the anatomy, the person’s fitness, and what they value. The table below summarizes the main pathways described by Mayo Clinic, the NHS, and MedlinePlus in neutral terms.

Option	What it involves	Typically considered for	Main trade-offs
Medicines and monitoring	Diuretics for fluid, heart-failure drug classes for a weak ventricle, periodic echocardiograms	Mild to moderate leaks; secondary regurgitation before any procedure	Does not fix the valve; relieves symptoms and supports the muscle
Surgical repair	Open or minimally invasive surgery reshaping leaflets and adding a ring around the annulus	Severe primary regurgitation in people fit for surgery	Most complete and durable repair; requires stopping the heart and a longer recovery
Surgical replacement	Removing the valve and implanting a mechanical or tissue valve	Valves too damaged to repair	Mechanical valves need lifelong anticoagulation; tissue valves wear over time
Transcatheter edge-to-edge repair	Clip placed via leg vein joining the leaflets	High surgical risk with primary disease; selected secondary regurgitation despite medicines	No chest incision, short stay; usually leaves some residual leak, anatomy-dependent
Transcatheter valve replacement	New valve delivered by catheter, mostly in research or restricted use	Selected anatomies unsuitable for clip or surgery	Evidence still developing

A point worth underlining: these are not competitors so much as tools for different situations. A sixty-year-old runner with a ruptured chord and a normal ventricle sits in a different category from an eighty-five-year-old with heart failure and a stretched ventricle, even though both have severe mitral regurgitation on paper. The heart team’s job is to match the tool to the person, and a good team will explain why one option fits better than another rather than simply announcing a plan.

What the evidence actually shows, read honestly

Three randomized trials anchor most of what is known, and each tells a slightly different story.

EVEREST II, published in 2011, randomized 279 people with mostly primary regurgitation who were reasonable surgical candidates to either clip repair or surgery. At one year, surgery reduced the leak more completely: the trial’s composite measure of freedom from death, further surgery, and significant residual leak was met by 55 percent of the clip group and 73 percent of the surgical group. The clip, however, produced fewer major adverse events in the first 30 days, 15 percent versus 48 percent, driven largely by blood transfusions in the surgical arm. The lesson was that the clip is safer up front but less complete, which is why it is reserved for people who cannot safely have surgery.

COAPT, published in 2018, enrolled 614 people with heart failure and severe secondary regurgitation despite maximal medicines. Over 24 months, the annualized rate of heart-failure hospitalization was 35.8 percent per patient-year with the clip plus medicines against 67.9 percent with medicines alone, and death from any cause was 29.1 percent versus 46.1 percent. These are striking figures, but they apply to a carefully selected population with large leaks and only moderately enlarged ventricles.

MITRA-FR, published the same year, randomized 304 broadly similar people in France and found no difference at 12 months in the combined rate of death or heart-failure hospitalization: 54.6 percent with the clip and 51.3 percent with medicines alone. Its participants had larger ventricles and smaller leaks relative to ventricle size, and medicines were less rigorously optimized before enrollment.

Taken together, the trials support a nuanced conclusion. Clip repair reliably reduces the leak. Whether that translates into fewer hospitalizations and longer life depends heavily on selecting people whose valve, rather than their muscle, is the dominant problem. That is why the heart-team assessment matters so much, and why the numbers above should be read as trial results in defined populations, not as promises for any individual.

What are the potential downsides of a mitral clip?

Every effective procedure carries risk, and clip repair is no exception. The list below is drawn from the safety reporting of the trials cited and from patient information published by Mayo Clinic and the NHS.

The most common issues are at the access site: bruising, bleeding, or occasionally a collection of blood in the groin. Because the catheters are large, this is more frequent than with a diagnostic angiogram, though serious bleeding is uncommon. Blood transfusion was the dominant adverse event in the clip arm of EVEREST II, at a rate far lower than in the surgical arm.

Procedure-specific risks include partial detachment of a leaflet from the clip, called single-leaflet device attachment, which can allow the leak to return and may need a second procedure. Rarely, a clip embolizes, meaning it comes loose entirely, which typically requires surgery. Injury to the leaflet or chords during grasping can make a later surgical repair harder, effectively converting a repairable valve into one that needs replacement. The transseptal puncture leaves a small hole between the atria; most close on their own, but a persistent shunt sometimes needs attention.

Mitral stenosis, a valve that is now too tight, is the mirror-image risk of joining the leaflets. The team measures the pressure gradient before releasing each clip specifically to avoid this, but a residual gradient can still limit how much blood passes through, especially with two or three clips.

General procedural risks apply as well: reaction to anesthesia, stroke from a dislodged clot or air, infection, kidney strain from contrast dye, and heart rhythm disturbances. In COAPT, freedom from device-related complications at 12 months was 96.6 percent, which is reassuring but not zero.

There is also the softer downside of an incomplete result. Some people leave with a leak reduced from severe to moderate rather than mild, and a moderate leak may still limit them. Honest teams discuss this possibility before the procedure, not after.

Mitral clip recovery time: what the first days and weeks usually look like

Mitral clip recovery time is short compared with open surgery, mainly because nothing has been cut except a small opening in a vein. What follows is the typical pattern described by Mayo Clinic and MedlinePlus, with the caveat that individual courses vary and the care team’s instructions override any general guide.

Immediately afterward, people wake in a recovery area and are asked to lie flat for several hours so the vein puncture can seal. A sore throat from the echo probe and grogginess from anesthesia are common and pass within a day. Most people are walking the same evening or the next morning. Hospital stays are usually measured in nights rather than weeks; discharge home within one to three days was the norm in the trial populations cited, though older or frailer people may stay longer.

The first week at home centers on the groin. A bruise the size of a hand is unremarkable, and mild tenderness is expected. Heavy lifting, straining, and vigorous exercise are typically restricted for about a week to protect the puncture site, while gentle walking is encouraged from day one. Many people notice easier breathing within days as the heart handles less backward flow, though fatigue can linger for a couple of weeks.

Medicines usually change little. Most people already take heart-failure or rhythm medicines, and these continue. A blood-thinning regimen, either an antiplatelet or an anticoagulant class depending on whether atrial fibrillation is present, is commonly prescribed for a period to reduce clot formation on the new metal until tissue covers it. The choice and duration belong to the prescribing clinician.

Follow-up typically includes an echocardiogram before discharge, another at around one month, and then at intervals the cardiologist sets, often six to twelve months. Cardiac rehabilitation is frequently offered and is worth accepting; it rebuilds fitness safely and gives a structured way to notice whether symptoms are improving as expected.

How long does a mitral clip last, and what happens if it fails?

The clip itself is a permanent implant. Within a few months, the body covers its fabric with a layer of tissue, and the leaflets heal to each other around it, forming a tissue bridge. Once that bridge has formed, the join is essentially part of the valve. The question people really mean when they ask how long a mitral clip lasts is whether the leak stays reduced.

The longest randomized data available come from the EVEREST II and COAPT programs, both of which have reported follow-up out to five years. The pattern in both is similar: when a clip is going to lose its grip, it tends to do so early, usually within the first months, and leaks that remain well controlled at one year most often stay controlled thereafter. Late worsening does occur, more commonly in secondary regurgitation where the underlying ventricle continues to enlarge and pulls on the segments of leaflet the clip does not hold.

Failure takes a few forms. The most common is recurrent regurgitation, either because a leaflet has slipped from the clip or because a new leak has opened beside it. Less often, the opening becomes too narrow. Rarely, a clip detaches entirely.

What happens next depends on anatomy and fitness. A second clip can often be placed beside the first if there is enough leaflet tissue and enough valve area to spare. If not, surgery is considered, and because the leaflets have been joined and scarred, that surgery is more likely to be a replacement than a repair. For people who were never surgical candidates in the first place, the options narrow to medicines and, in selected cases, investigational transcatheter valve replacement.

This is why teams weigh the clip against the future. In a relatively young person with repairable primary disease, a clip that later fails may have cost the chance of a durable surgical repair. In a frail older person, that trade-off looks very different. Neither view is universally right; both belong in the conversation.

What people often get wrong about how mitral valve clip repair works

Several misunderstandings come up repeatedly in clinic, and clearing them away makes the decision easier.

The first is that the clip replaces the valve. It does not. The original leaflets stay in place and keep doing the work; the clip simply holds them together at one point. That is why leaflet quality matters so much to eligibility, and why a badly calcified or torn leaflet may not be suitable.

The second is that a clip is a minor procedure in the way a stent is. It is less invasive than surgery, and recovery is faster, but it involves general anesthesia, a puncture through the wall between the heart’s upper chambers, and large catheters inside a beating heart. The trials cited record real complications. Treating it as trivial leads to disappointment when the groin aches or the first echo shows a moderate residual leak.

The third is that the clip fixes heart failure. In secondary regurgitation, the leak is a consequence of a weakened muscle, not its cause. The MITRA-FR trial is the clearest illustration that reducing the leak does not automatically improve outcomes when the muscle disease dominates. The clip works best as one part of heart-failure management, alongside medicines, devices such as pacemakers where indicated, and rehabilitation.

The fourth is that a successful clip means no more echocardiograms. Follow-up imaging is how early leaflet detachment or a rising gradient is caught while options remain.

The fifth, and the one that most affects choice, is that the clip is simply the modern alternative to surgery for everyone. For people who are fit for an operation and have primary disease, surgical repair remains the more complete and durable option in the published evidence. The clip earned its place by offering something to people who previously had nothing beyond medicines, not by displacing surgery for those who can have it.

Questions to ask your care team before agreeing to a clip

A good consultation leaves you knowing not just what is planned but why. These questions, phrased so they can be asked in a single sitting, tend to surface the reasoning behind a recommendation.

• Is my regurgitation primary or secondary, and how confident are you in that classification?
• If it is secondary, have my heart-failure medicines been fully optimized, and for how long?
• Why am I not a candidate for surgical repair, and would that change if my health improved?
• Does my valve anatomy suit a clip well, adequately, or marginally? What specifically makes it so?
• How many clips do you expect to need, and what residual leak grade would you consider a good result for me?
• What is the chance the valve ends up too narrow, and how do you guard against that during the procedure?
• If the clip does not hold, what would my options be afterward, and would surgery still be possible?
• Which blood-thinning medicines will I need after, and for roughly how long?
• What symptoms should improve, by when, and what would tell us the procedure has not helped?
• How will follow-up be organized, and who do I call between appointments?

Two further questions are less clinical but just as useful. Ask what the team would do if the person in front of them were their own parent, and ask what happens if you decide to do nothing for now. The answers reveal how the team weighs urgency, and they give you a baseline against which to judge the recommendation. Bring someone with you, write the answers down, and do not hesitate to request a second consultation if anything remains unclear. Decisions about permanent implants deserve time.

When to call your doctor after mitral clip repair

Most recoveries are uneventful, but a few signs need prompt attention. The list below is a general guide drawn from post-procedure advice published by Mayo Clinic and the NHS; the discharge instructions from your own team take precedence.

Call emergency services immediately, do not wait for a clinic callback, if you experience sudden severe breathlessness or breathlessness that wakes you and is not relieved by sitting up; chest pain or pressure; sudden weakness, numbness, facial drooping, trouble speaking, or loss of vision, which can signal a stroke; fainting or near-fainting; or a groin wound that starts to bleed heavily or swells rapidly. Firm, direct pressure on a bleeding groin while help is on the way can be lifesaving.

Contact your cardiology team the same day for a fever above 38 °C (100.4 °F) or chills, which can indicate infection; increasing redness, warmth, or pus at the puncture site; a new or rapidly enlarging lump in the groin; a heart rate that is persistently very fast or irregular when it was not before; new or worsening ankle or abdominal swelling; weight gain of more than about two kilograms (roughly four to five pounds) over two or three days, which suggests fluid retention; or a return of the breathlessness the procedure was meant to relieve.

Mention at your next scheduled visit, or sooner if it worries you, any dizziness on standing, unusual bruising or bleeding from gums or in urine while on blood thinners, or a sense that your exercise tolerance has plateaued or slipped.

The reason for vigilance in the first weeks is that the two most consequential problems, leaflet detachment and infection of the implant, are both more treatable when caught early. A phone call that turns out to be unnecessary costs little. A delayed one can cost options.

Frequently asked questions

How does mitral valve clip repair reduce regurgitation without replacing the valve?

The clip grasps the free edges of both leaflets at the spot where they fail to meet and holds them together permanently. This creates a double-orifice valve, so each half of the valve closes on a smaller frame with less distance to travel. Joining the leaflets also pulls the valve ring inward, and over months the unloaded heart chambers can shrink, which further improves how the leaflets seal.

What are the potential downsides of a mitral clip?

The main downsides are groin bleeding or bruising from the large catheters, a leaflet slipping free of the clip so the leak returns, a valve left too narrow if the opening is over-reduced, and a small persistent hole between the atria from the transseptal puncture. Rarer risks include stroke, infection, clip detachment, and leaflet damage that makes later surgical repair harder. Some people are left with a moderate rather than mild residual leak.

How long does it take to recover from mitral valve clip repair?

Most people go home within one to three days and are walking the day after the procedure, according to trial reports and patient guidance from Mayo Clinic. Groin soreness and bruising settle over about a week, during which heavy lifting is usually restricted. Many notice easier breathing within days, while full energy can take a few weeks to return. Cardiac rehabilitation is often recommended to rebuild fitness safely.

What happens if a mitral clip fails?

Failure usually means the leak has returned, most often because one leaflet has detached from the clip, and it is typically detected on a follow-up echocardiogram. If enough leaflet tissue and valve area remain, a second clip can sometimes be placed beside the first. Otherwise surgery is considered, and because the leaflets have been joined and scarred, that surgery is more likely to be a valve replacement than a repair.

How long does a mitral clip last?

The clip is a permanent implant that becomes covered by the body’s own tissue within months, forming a lasting bridge between the leaflets. Whether the leak stays reduced is the more relevant question. Five-year follow-up from the EVEREST II and COAPT programs shows that leaks well controlled at one year most often remain so, while problems, when they occur, cluster in the first few months after the procedure.

Is the mitral valve TEER procedure the same as a mitral clip?

Yes, in everyday use. Transcatheter edge-to-edge repair, abbreviated TEER, is the generic clinical name for placing a clip through a catheter to join the mitral leaflets. It has also been called transcatheter mitral valve repair or TMVr. People often refer to it by the brand name of the most widely used device, but the technique, the route through the leg vein, and the double-orifice principle are the same regardless of the label.

What are the mitral regurgitation treatment options if I am not suitable for a clip?

Options depend on why you are unsuitable. If the anatomy does not fit a clip but you are fit for surgery, surgical repair or replacement remains standard. If neither is possible, management centers on heart-failure medicines, diuretics for fluid, rhythm control where atrial fibrillation is present, and cardiac rehabilitation. In selected cases, transcatheter mitral valve replacement is available through research programs. Your heart team can explain which pathway applies to you.

Does the clip fix heart failure caused by a weak heart muscle?

Not by itself. In secondary regurgitation the leak is a consequence of an enlarged, weakened ventricle, so the clip treats a symptom of the muscle disease rather than the disease itself. The COAPT trial showed benefit when the leak was large relative to the ventricle and medicines were already optimized, while MITRA-FR showed none in a population with larger ventricles. The clip works best as one part of comprehensive heart-failure care.

Will I need blood thinners after mitral clip repair?

Usually, for a period. Until tissue grows over the clip, its metal and fabric surfaces can attract clots, so an antiplatelet or anticoagulant class of medicine is commonly prescribed. People who already take an anticoagulant for atrial fibrillation typically continue it. The specific medicine, whether it is combined with another, and how long it continues are decisions for your prescribing clinician based on your bleeding and clotting risks.

Can more than one clip be placed on the same valve?

Yes. When the leak extends along a longer stretch of the leaflet edge, or when a single clip leaves too much residual leak, a second clip is commonly placed beside the first during the same procedure, and occasionally a third. Each additional clip narrows the valve opening further, so the team checks the pressure gradient across the valve before committing to another, balancing leak reduction against the risk of creating a valve that is too tight.

References

• MedlinePlus: Mitral regurgitation, chronic
• NHS: Mitral valve problems
• Stone GW et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure (COAPT), NEJM 2018, PubMed
• Obadia JF et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation (MITRA-FR), NEJM 2018, PubMed

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.